The Role of Neoantigens in Cancer Immunotherapy
Somatic mutation-derived neoantigens, expressed only on tumor cells, may elicit antitumor T-cell responses in cancer immunotherapies with minimal immune tolerance. Neoantigens can be identified by multiple bioinformatics technologies, mainly based on whole-exome sequencing. Personalized cancer vacci...
Main Authors: | Yueting Zhu, Jiyan Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.682325/full |
Similar Items
-
Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?
by: Thomas C. Wirth, et al.
Published: (2017-12-01) -
Identification and Targeting of Mutant Peptide Neoantigens in Cancer Immunotherapy
by: Daniel J. Verdon, et al.
Published: (2021-08-01) -
The Clinical Application of Neoantigens in Esophageal Cancer
by: Yi-Min Gu, et al.
Published: (2021-07-01) -
Neoantigens: The Novel Precision Cancer Immunotherapy
by: Tiantian Zhang, et al.
Published: (2023-10-01) -
Targeting neoantigens for cancer immunotherapy
by: Xuan Zhao, et al.
Published: (2021-07-01)